Trump Administration Considers Covering Weight Loss Drugs for Medicare, Medicaid
The Trump administration is reportedly planning a significant five-year pilot program aimed at providing access to cutting-edge weight loss medications, including popular drugs like Ozempic, Wegovy, Mounjaro,…
Weight Loss Drugs: New Hope for Stroke Prevention and Brain Recovery
New groundbreaking research is shedding light on the unexpected neuroprotective potential of glucagon-like peptide-1 (GLP-1) receptor agonists, commonly known as weight loss drugs, suggesting they could play…